BrightGene Investors
BrightGene Bio-medical technology Co.,Ltd., is a leading Chinese biopharmaceutical company in small molecules and nucleotide drugs areas. Advised by China-based venture capital fund Laurel Venture Capital, BrightGene invests in all stage therapeutics and innovations.
Employee Number:
819
Headquarters:
Suzhou, Jiangsu, China
Founded Date:
2001
Technology:
Other
Industry:
Venture Funds